D

Anika Therapeutics, Inc. ANIK

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$12.76$13.84
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Revenue 9.42% -2.50% -7.91% -12.61% -12.33%
Total Other Revenue -- -- -- -- --
Total Revenue 9.42% -2.50% -7.91% -12.61% -12.33%
Cost of Revenue -10.45% -39.56% -33.05% -30.44% -24.82%
Gross Profit 25.49% 55.56% 25.36% 8.82% 1.27%
SG&A Expenses 3.39% -9.46% -11.18% -19.69% -23.69%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -0.85% -21.50% -19.34% -21.81% -20.28%
Operating Income 99.03% 91.75% 65.71% 62.32% 57.31%
Income Before Tax 90.04% 91.77% 68.58% 69.68% 64.88%
Income Tax Expenses -117.52% -96.29% -86.91% -89.16% -48.49%
Earnings from Continuing Operations 98.20% 92.39% 71.53% 72.96% 61.22%
Earnings from Discontinued Operations 91.96% 96.62% 100.08% 95.38% 69.09%
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 94.65% 93.76% 80.50% 80.70% 66.12%
EBIT 99.03% 91.75% 65.71% 62.32% 57.31%
EBITDA 191.07% 110.63% 77.88% 74.66% -220.53%
EPS Basic 94.37% 93.57% 79.57% 80.25% 65.68%
Normalized Basic EPS 116.96% 98.66% 68.66% 64.53% 64.87%
EPS Diluted 93.83% 93.28% 79.31% 79.88% 65.54%
Normalized Diluted EPS 115.47% 98.18% 68.75% 64.62% 65.03%
Average Basic Shares Outstanding -5.44% -4.23% -3.24% -2.60% -2.20%
Average Diluted Shares Outstanding -4.41% -3.21% -2.41% -1.77% -2.16%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --